Health Care & Life Sciences » Pharmaceuticals | Lee's Pharmaceutical Holdings Ltd.

Lee's Pharmaceutical Holdings Ltd. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
697
955
922
930
1,009
1,138
Cost of Goods Sold (COGS) incl. D&A
194
285
274
262
326
391
Gross Income
503
671
648
668
682
746
SG&A Expense
333
447
416
418
457
571
EBIT
170
224
232
251
227
176
Unusual Expense
-
-
10
10
50
28
Non Operating Income/Expense
7
14
39
45
93
254
Interest Expense
2
3
3
4
4
5
Pretax Income
176
228
254
283
258
446
Income Tax
27
41
41
50
55
57
Consolidated Net Income
149
187
213
232
203
390
Net Income
150
193
229
252
233
418
Net Income After Extraordinaries
150
193
229
252
233
418
Net Income Available to Common
150
193
229
252
233
418
EPS (Basic)
0.28
0.36
0.40
0.43
0.39
0.71
Basic Shares Outstanding
530
543
576
589
591
592
EPS (Diluted)
0.27
0.34
0.39
0.43
0.39
0.70
Diluted Shares Outstanding
546
560
583
592
592
595
EBITDA
186
253
276
296
285
241
Other Operating Expense
-
-
-
-
2
-
Non-Operating Interest Income
3
4
5
3
7
10
Minority Interest Expense
1
6
16
20
30
29
Equity in Affiliates (Pretax)
2
1
29
12
15
16

About Lee's Pharmaceutical Holdings

View Profile
Address
1/F, Building 20 East
Hong Kong
Hong Kong
Employees -
Website http://www.leespharm.com
Updated 07/08/2019
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. It operates through the Proprietary Products and Licensed-in Products segments. The Proprietary Products segment involves in manufacturing and selling self-development pharmaceutical products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.